中东和非洲过敏免疫疗法市场预测至 2027 年 - COVID-19 影响和治疗区域分析（皮下免疫疗法 (SCIT) 和舌下免疫疗法 (SLIT)）；过敏类型（过敏性鼻炎、哮喘、食物过敏、毒液过敏等）；分销渠道（医院药房、零售药房和网上药房）和国家
No. of Pages: 75 | Report Code: TIPRE00016213 | Category: Life Sciences
No. of Pages: 75 | Report Code: TIPRE00016213 | Category: Life Sciences
过敏原免疫疗法，又称低敏疗法或脱敏疗法，是一种针对过敏症的医学治疗方法。向患者给予一定剂量的过敏原，从而减少炎症，从而通过阻断抗体功能，导致免疫系统对物质的敏感性降低。过敏免疫疗法的主要治疗目标包括减轻症状、减少对症药物的使用以及改善过敏相关的生活质量。
中东和中东地区2019年非洲过敏免疫疗法市场价值为1.3787亿美元，预计到2027年将达到2.9762亿美元；预计在预测期内复合年增长率为 10.2%。中东和中东地区由于过敏性疾病患病率的增加和舌下制剂技术的进步等关键驱动因素，非洲过敏免疫疗法市场预计将增长。然而，与使用过敏免疫疗法、医疗保健支出受限以及各地区监管差异相关的缺点可能会阻碍预测期内市场的增长。
中东和非洲过敏免疫疗法市场根据治疗分为皮下免疫疗法（SCIT）和舌下免疫疗法（SLIT）。 2019年，皮下免疫治疗（SCIT）细分市场占据最大市场份额，然而，舌下免疫治疗（SLIT）细分市场预计在预测期内将以最快的速度增长。根据过敏类型，中东和非洲过敏免疫疗法市场分为过敏性鼻炎、哮喘、食物过敏、毒液过敏等。过敏性鼻炎细分市场在 2019 年过敏免疫疗法市场中占有最高份额。此外，预计该细分市场在预测期内将出现显着增长。
根据分销渠道，市场被细分分为医院药房、零售药房和网上药房。 2019年，医院药房设置细分市场占据最大份额，预计同一药房细分市场在预测期内将以最快的速度增长。
中东和中东地区的一些主要一手和二手来源。报告中包含的非洲过敏免疫疗法市场 Celsion Corporation；世界过敏组织（WAO）；世界卫生组织(WHO)；沙特过敏、哮喘和免疫学会和南非过敏学会(ALLSA)。
按治疗方法
按过敏类型< /span>
按分布渠道
按国家/地区
公司简介
Strategic insights for Middle East and Africa Allergy Immunotherapies involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 137.87 Million |
| Market Size by 2027 | US$ 297.62 Million |
| Global CAGR (2019 - 2027) | 10.2% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By 治疗
|
| Regions and Countries Covered | 中东和非洲
|
| Market leaders and key company profiles |
The regional scope of Middle East and Africa Allergy Immunotherapies refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Middle East and Africa Allergy Immunotherapies Market is valued at US$ 137.87 Million in 2019, it is projected to reach US$ 297.62 Million by 2027.
As per our report Middle East and Africa Allergy Immunotherapies Market, the market size is valued at US$ 137.87 Million in 2019, projecting it to reach US$ 297.62 Million by 2027. This translates to a CAGR of approximately 10.2% during the forecast period.
The Middle East and Africa Allergy Immunotherapies Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Allergy Immunotherapies Market report:
The Middle East and Africa Allergy Immunotherapies Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Allergy Immunotherapies Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Allergy Immunotherapies Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East and Africa Allergy Immunotherapies Market
